AAREY DRUGS & PHARMACEUTICALS
|
The Current P/E Ratio of AAREY DRUGS & PHARMACEUTICALS is 55.16.
| Share Price | ₹87.9 | Jul 06,2026 |
| Market Cap | ₹249.5 Cr | |
| Earnings-TTM | ₹4.5 Cr | TTM-Standalone Results |
| Price/Earnings | 55.16x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of AAREY DRUGS & PHARMACEUTICALS
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹249.5 Cr] as on Jul 06,2026
(/) Earnings [ ₹4.5 Cr] based on TTM-Standalone Results
(=) P/E Ratio [ 55.16x ]
Thus, for AAREY DRUGS & PHARMACEUTICALS , the investors are currently willing to pay 55.16 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of AAREY DRUGS & PHARMACEUTICALS !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of AAREY DRUGS & PHARMACEUTICALS over the last five years.
Historical PE (Price/Earnings) ratio chart of AAREY DRUGS & PHARMACEUTICALS
PE Ratio Performance Analysis for AAREY DRUGS & PHARMACEUTICALS
- AAREY DRUGS & PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 18.18x.
- AAREY DRUGS & PHARMACEUTICALS 's operated at median p/e ratio of 16.03x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, AAREY DRUGS & PHARMACEUTICALS 's p/e ratio peaked in Mar2024 at 26.76x.
- AAREY DRUGS & PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2021 of 8.33x.
How does AAREY DRUGS & PHARMACEUTICALS 's P/E Ratio benchmark against top 10 peers in Trading Industry?
| Peer Comparison (Trading Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| AAREY DRUGS & PHARMACEUTICALS | 4.52 | 55.16 | 249.5 |
| ADANI ENTERPRISES LTD | 9,693.51 | 43.06 | 417,355.0 |
| PREMIER ENERGIES LTD | 1,504.57 | 30.84 | 46,405.2 |
| ADITYA INFOTECH LTD | 367.96 | 115.64 | 42,552.3 |
| AEGIS LOGISTICS LTD | 1,106.63 | 44.62 | 49,375.2 |
| REDINGTON LTD | 1,284.15 | 16.84 | 21,623.9 |
| RRP SEMICONDUCTOR LTD | -7.75 | -1,562.81 | 12,118.0 |
| HONASA CONSUMER LTD | 200.33 | 76.29 | 15,282.4 |
| LLOYDS ENTERPRISES LTD | 374.53 | 31.69 | 11,870.5 |
| MMTC LTD | 212.07 | 46.86 | 9,937.5 |
| CELLO WORLD LTD | 331.51 | 24.47 | 8,110.9 |
Trading Industry Benchmark (Top 10) PE Analysis vs AAREY DRUGS & PHARMACEUTICALS 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | -1,562.81x |
| Max industry PE | 115.64x |
| Median industry PE | 43.06x |
| Average industry PE | -97.94x |
You may also like the below Video Courses